Alembic Pharmaceuticals has raised funds aggregating to Rs 350 crore via private placement. The NCD Committee of the company at their meeting held on December 14, 2018 has allotted 1,500 9% Rated Unsecured Listed Redeemable Non-Convertible Debentures (NCDs) of Rs 10 lakh per NCD aggregating to Rs 150 crore under Tranche I, and 2,000 9% Rated Unsecured Listed Redeemable NCDs of Rs 10 lakh per NCD aggregating to Rs 200 crore under Tranche II. The said NCDs shall be listed on the National Stock Exchange of India.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.
